A Conservative former minister said he has lost more than five stone in weight after using weight-loss injections, as he ...

In the ongoing quest to expand semaglutide’s clinical pedigree and cement the GLP-1's market position, Novo Nordisk is ...

A study has suggested that the use of weight-loss jabs may be associated with wider health benefits, including a lower risk ...

( MENAFN - Swissinfo) Swiss medicines regulator Swissmedic has taken legal action against media houses in Switzerland for ...

As drugs emerge as vital to the Government’s anti-obesity strategy, BBC Panorama is shedding light on the pharmaceuticals ...

A major new study has highlighted significant health risks associated with popular weight loss injections such as Ozempic, ...

This year, revolutionary anti-obesity drugs Wegovy and Ozempic (manufactured by Danish drugmaker Novo Nordisk), and Eli Lilly ...

Over the last year, weight loss jabs have become highly popular, particularly as the NHS began offering Wegovy in late 2023 and will start offering Mounjaro to patients in March 2025. There has also ...

While it's illegal to sell certain substances without a prescription, it's possible that you could be sold fake weight loss ...

Wegovy, the weight-loss brand of semaglutide, has a recommended maintenance dose of 2.4 mg. Novo ran the Phase III STEP UP ...

not for people who just want to lose some weight." Wegovy is taken via an injection once a week. Should you meet the eligibility criteria and are prescribed Wegovy, your healthcare team will give ...